NXEN 주가 차트
NXEN 수입
Nexien Biopharma Inc
$0
0%
$0
종가: May 08, 16:00:00 GMT-4
$0
0%
$0
애프터마켓: May 08, 20:00:00 GMT-4
뒤로
Nexien Biopharma Inc (NXEN) 수입
주요 통계
이전 종가
$0.0001
시가
$0.0018
일일 범위
$0.0001 - $0.0018
52주 범위
$0.0001 - $0.0145
거래량
115.0K
평균 거래량
35.8K
배당수익률
--
EPS(TTM)
-0.00
시가총액
$7.0K
NXEN란 무엇인가요?
Nexien BioPharma, Inc. engages in the development and commercialization of Food and Drug Administration-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company is headquartered in Glendale, Colorado. The company went IPO on 2001-07-11. The firm is focused on developing and commercializing United States Food and Drug Administration (FDA)-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders and medical conditions. The firm is utilizing cannabinoids as the active pharmaceutical ingredients to develop synthetic pharmaceuticals in strict accordance with the U.S. FDA pre-clinical and clinical pathways. Its flagship research and development programs are focused on advancing formulations that have the potential to improve the treatment outcomes of certain convulsive disorders and neuromuscular disorders, which includes the treatment of myotonic dystrophy. The firm's wholly owned subsidiaries include Intiva BioPharma Inc., NexN Inc. (NexN) and NexDM Inc.
